Changes in recreational drug use, reasons for those changes and their consequence during and after the COVID-19 pandemic in the UK
(2025) In Comprehensive Psychiatry 140.- Abstract
Changes in drug use in the general population during the COVID-19 pandemic and their long-term consequences are not well understood. We employed natural language processing and machine learning to analyse a large dataset of self-reported rates of and reasons for drug use during the pandemic, along with their associations with anxiety, depression and substance use problems post-pandemic. Our findings revealed a transient decrease in drug use at the pandemic's peak, primarily attributed to reduced social opportunities. Conversely, some participants reported increased drug use for self-medication, boredom, and lifestyle disruptions. While users of psychedelics and MDMA had anxiety and depression rates similar to non-users, users of opioid... (More)
Changes in drug use in the general population during the COVID-19 pandemic and their long-term consequences are not well understood. We employed natural language processing and machine learning to analyse a large dataset of self-reported rates of and reasons for drug use during the pandemic, along with their associations with anxiety, depression and substance use problems post-pandemic. Our findings revealed a transient decrease in drug use at the pandemic's peak, primarily attributed to reduced social opportunities. Conversely, some participants reported increased drug use for self-medication, boredom, and lifestyle disruptions. While users of psychedelics and MDMA had anxiety and depression rates similar to non-users, users of opioid agonists and depressants—representing one in ten active drug users—reported greater mental health challenges post-pandemic. These results suggest that a subset of active drug users with distinct profiles faces elevated risks, particularly for anxiety and depression, and may benefit from targeted support.
(Less)
- author
- Bălăeţ, Maria
; Zadel, Ana
LU
; Lingford-Hughes, Anne ; Paterson, Louise M. ; Chamberlain, Samuel R. ; Trender, William ; Hellyer, Peter J. and Hampshire, Adam
- organization
- publishing date
- 2025-07
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Benzodiazepines, COVID-19, Large scale survey, Longitudinal research, MDMA, Mental health, Natural language processing, Opioids, Psychedelics, Recreational drug use
- in
- Comprehensive Psychiatry
- volume
- 140
- article number
- 152598
- publisher
- W.B. Saunders
- external identifiers
-
- pmid:40250155
- scopus:105002679339
- ISSN
- 0010-440X
- DOI
- 10.1016/j.comppsych.2025.152598
- language
- English
- LU publication?
- yes
- id
- ef05ae34-3484-48c2-9466-594062843ddb
- date added to LUP
- 2025-08-06 10:40:15
- date last changed
- 2025-08-06 13:26:52
@article{ef05ae34-3484-48c2-9466-594062843ddb, abstract = {{<p>Changes in drug use in the general population during the COVID-19 pandemic and their long-term consequences are not well understood. We employed natural language processing and machine learning to analyse a large dataset of self-reported rates of and reasons for drug use during the pandemic, along with their associations with anxiety, depression and substance use problems post-pandemic. Our findings revealed a transient decrease in drug use at the pandemic's peak, primarily attributed to reduced social opportunities. Conversely, some participants reported increased drug use for self-medication, boredom, and lifestyle disruptions. While users of psychedelics and MDMA had anxiety and depression rates similar to non-users, users of opioid agonists and depressants—representing one in ten active drug users—reported greater mental health challenges post-pandemic. These results suggest that a subset of active drug users with distinct profiles faces elevated risks, particularly for anxiety and depression, and may benefit from targeted support.</p>}}, author = {{Bălăeţ, Maria and Zadel, Ana and Lingford-Hughes, Anne and Paterson, Louise M. and Chamberlain, Samuel R. and Trender, William and Hellyer, Peter J. and Hampshire, Adam}}, issn = {{0010-440X}}, keywords = {{Benzodiazepines; COVID-19; Large scale survey; Longitudinal research; MDMA; Mental health; Natural language processing; Opioids; Psychedelics; Recreational drug use}}, language = {{eng}}, publisher = {{W.B. Saunders}}, series = {{Comprehensive Psychiatry}}, title = {{Changes in recreational drug use, reasons for those changes and their consequence during and after the COVID-19 pandemic in the UK}}, url = {{http://dx.doi.org/10.1016/j.comppsych.2025.152598}}, doi = {{10.1016/j.comppsych.2025.152598}}, volume = {{140}}, year = {{2025}}, }